MAURA KING: Open Payments
NPI 1740916774 · KALISPELL, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 16 payments from 13 companies in 2025. Trend: 2023 $4,222 · 2024 $4,139 · 2025 $382
Food & beverage: $290Education: $92
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $33 |
| Genentech USA, Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $19 |
| Incyte Corporation | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| UCB, Inc. | 1 | $14 |
Products named: DUPIXENT, XOLAIR, ILUMYA, SPEVIGO, SKYRIZI, AYVAKIT, OPZELURA, LIBTAYO.
Industry payments across MT — which companies pay providers there.
